Reports fourth quarter revenue of $0.7 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.11)Reports ...
FIGS, Inc. ( FIGS) Q4 2025 Earnings Call February 26, 2026 5:00 PM EST Good afternoon. Thank you for attending the FIGS Fourth Quarter Fiscal 2025 Earnings Conference Call. My name is Cameron, and ...
Record full year 2025 revenue of $236.3 million increased 15% compared to prior yearOperating Cash flow improvement of $22 million in full year 2025Generated $10 million of free cash flow in the ...
Pfizer Inc. and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for ...
News-Medical.Net on MSN
Disrupted iron levels after SARS-CoV-2 infection may trigger long COVID
Problems with iron levels in the blood and the body's ability to regulate this important nutrient as a result of SARS-CoV-2 ...
Bristol Myers Squibb (NYSE: BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results